Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Hilgenfeld

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Future Medicinal Chemistry|March 24, 2011
Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academiaRolf Hilgenfeld
The FEBS Journal|July 22, 2014
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designRolf Hilgenfeld
The EMBO Journal|November 1, 2016
Zika virus NS1, a pathogenicity factor with many facesRolf Hilgenfeld
Current Topics in Medicinal Chemistry|February 20, 2010
Recent advances in targeting viral proteases for the discovery of novel antiviralsHolger Steuber, Rolf Hilgenfeld
FEBS Letters|August 30, 2017
RNA-virus proteases counteracting host innate immunityJian Lei, Rolf Hilgenfeld
Cellular and Molecular Life Sciences : CMLS|July 19, 2012
Architecture and regulation of HtrA-family proteins involved in protein quality control and stress responseGuido Hansen, Rolf Hilgenfeld
Virus Genes|November 21, 2014
Acquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirusAditi Shukla, Rolf Hilgenfeld
Chemistry & Biology|April 28, 2006
Sometimes intermediates. Do the job!Rolf Hilgenfeld, Ksenia Pumpor
Antiviral Research|September 10, 2013
From SARS to MERS: 10 years of research on highly pathogenic human coronavirusesRolf Hilgenfeld, Malik Peiris
EXS|March 5, 2003
The role of protein 3D-structures in the drug discovery processAlexander Hillisch, Rolf Hilgenfeld
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Future Medicinal Chemistry|March 24, 2011
Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academiaRolf Hilgenfeld
The FEBS Journal|July 22, 2014
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designRolf Hilgenfeld
The EMBO Journal|November 1, 2016
Zika virus NS1, a pathogenicity factor with many facesRolf Hilgenfeld
Current Topics in Medicinal Chemistry|February 20, 2010
Recent advances in targeting viral proteases for the discovery of novel antiviralsHolger Steuber, Rolf Hilgenfeld
FEBS Letters|August 30, 2017
RNA-virus proteases counteracting host innate immunityJian Lei, Rolf Hilgenfeld
Cellular and Molecular Life Sciences : CMLS|July 19, 2012
Architecture and regulation of HtrA-family proteins involved in protein quality control and stress responseGuido Hansen, Rolf Hilgenfeld
Virus Genes|November 21, 2014
Acquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirusAditi Shukla, Rolf Hilgenfeld
Chemistry & Biology|April 28, 2006
Sometimes intermediates. Do the job!Rolf Hilgenfeld, Ksenia Pumpor
Antiviral Research|September 10, 2013
From SARS to MERS: 10 years of research on highly pathogenic human coronavirusesRolf Hilgenfeld, Malik Peiris
EXS|March 5, 2003
The role of protein 3D-structures in the drug discovery processAlexander Hillisch, Rolf Hilgenfeld
Pageof 15